Abstract: The method for on-screen animation includes providing a digital world including image object elements and defining autonomous image entities (AIE). Each AIE may represent a character or an object that is characterized by i) attributes defining the AIE relatively to the image objects elements of the digital world, and ii) behaviours for modifying some of the attributes. Each AIE is associated to animation clips allowing representing the AIE in movement in the digital world. Virtual sensors allow the AIE to gather data information about image object elements or other AIE within the digital world. Decision trees are used for processing the data information resulting in selecting and triggering one of the animation cycle or selecting a new behaviour. A system embodying the above method is also provided. The method and system for on-screen animation of digital entities according to the present invention can be used for creating animation for movies, for video games, and for simulation.

Abstract: A digital media access device having several sockets (13, 14, 20, 21, 22) for accessing different removable storage media such as memory cards (13), a means for allowing the user to identify the type of removable storage media and means for indicating (18, 23) which slot to use for the identified storage media. An eject button (29) is provided for ejecting from a plurality of slots. So lenoid (19) actuated shutters are also provided to prevent mis-insertion of memory cards.

Abstract: The invention is a method for inhibiting activation of the human A3 adenosine receptor with adenosine, by treating the receptor a compound of the formula ##STR1## to treat asthma.

Abstract: A class of 2,6-diarylpyridazinones of general structural formula I have been identified that exhibit exhibit immunosuppressant activity with human T-lymphocytes, and are useful as an immunosuppressants. ##STR1## or a pharmaceutically acceptable salt, hydrate or crystal form thereof, wherein:when M is S, R.sup.1 and R.sup.2 are selected from the following combinations:when R.sup.2 is 4-chloro, then R.sup.1 is 4-OCH.sub.3,2 -CH.sub.3, 4-Cl, 4-CH3,3-Cl, 3-CH3, 2-Cl, 4-H, 4-Br, 3-NO.sub.2 ; andwhen R.sup.2 is H, then R.sup.1 is 4-OCH.sub.3, andwhen M is --SO.sub.2 --, then R.sup.2 is H and R.sup.1 is 4-OCH.sub.3.As an immunosuppressant, these compounds are useful in the treatment of autoimmune diseases, the prevention of rejection of foreign organ transplants and/or related afflictions, diseases and illnesses.